牛叉诊股

[{"date":"2025.11.10","stock":"1.15","trade":"0.84","ind":"0.53"},{"date":"2025.11.07","stock":"1.71","trade":"0.89","ind":"-0.25"},{"date":"2025.11.06","stock":"0.14","trade":"-0.37","ind":"0.97"},{"date":"2025.11.05","stock":"-0.18","trade":"0.46","ind":"0.23"},{"date":"2025.11.04","stock":"-1.24","trade":"-0.65","ind":"-0.41"},{"date":"2025.11.03","stock":"-0.75","trade":"0.77","ind":"0.55"},{"date":"2025.10.31","stock":"1.61","trade":"2.11","ind":"-0.81"},{"date":"2025.10.30","stock":"-3.08","trade":"-1.13","ind":"-0.73"},{"date":"2025.10.29","stock":"-0.43","trade":"-0.32","ind":"0.70"},{"date":"2025.10.28","stock":"-0.81","trade":"-0.54","ind":"-0.22"},{"date":"2025.10.27","stock":"1.04","trade":"-0.12","ind":"1.18"},{"date":"2025.10.24","stock":"0.30","trade":"-0.63","ind":"0.71"},{"date":"2025.10.23","stock":"0.17","trade":"-0.36","ind":"0.22"},{"date":"2025.10.22","stock":"0.17","trade":"0.70","ind":"-0.07"},{"date":"2025.10.21","stock":"-0.48","trade":"0.86","ind":"1.36"},{"date":"2025.10.20","stock":"0.52","trade":"0.20","ind":"0.63"},{"date":"2025.10.17","stock":"-0.09","trade":"-0.94","ind":"-1.95"},{"date":"2025.10.16","stock":"0.66","trade":"0.75","ind":"0.10"},{"date":"2025.10.15","stock":"0.35","trade":"1.37","ind":"1.22"},{"date":"2025.10.14","stock":"0.44","trade":"0.32","ind":"-0.62"},{"date":"2025.10.13","stock":"-0.40","trade":"-0.86","ind":"-0.19"}]

羚锐制药,上证指数,中药指数

压力支撑

该股压力位为22.60元，支撑位为22.34元。

[{"text":"\u538b\u529b\u4f4d","value":"22.60","date":1762704000,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"22.34","date":1762704000,"color":"0x0b52a1"}]

多空趋势

多头行情中，目前处于回落整理阶段且下跌趋势有所减缓。

macd kdj boll asi bias rsi wr vr

资金面诊股

诊断结果：4.6资金面打败了53%的股票主力控盘前10的股票

资金面得分最高的股票

主力控盘

据统计，近10日内主力没有控盘。

没有控盘
轻度控盘
中度控盘
高度控盘

行业资金

中药行业，近5日资金总体无进出。

更新时间：11月11日 08:12

机构今日流向(万元)	2136.97	机构5日流向(万元)	796.49
机构10日流向(万元)	-162.00	机构20日流向(万元)	-4213.83

机构持仓

2025-06-30 与 2024-12-31 相比，主力机构持仓量减少1726.61万股，其中基金数没有增加，主力净增仓2家，暂未发现中长期投资价值。

截止2025-06-30，共325家主力机构（基金320家，一般法人2家，社保基金2家，保险公司1家），持仓量总计27226.71万股，占流通A股48.12%
其中，基金持仓与2024-12-31相比：
增仓：74家，增持 1227.86万股
减仓：74家，减持 2794.12万股
新出现在主力名单中：153家，持有2461.73万股
从主力名单中消失：151家，原持有2875.16万股

消息面诊股

诊断结果：5.5消息面打败了54%的股票今日有利好新闻的公司

近期该股消息面总体多空平衡，没有较强的利好或利空趋势。

消息面得分最高的股票

消息列表

一般消息	股东大会	临时股东大会	2025-10-30
一般消息	重大事项	公司股东股份解押	2025-09-26
一般消息	分红转增	不分配不转增	2025-08-20
利好	重大事项	参股拟上市公司或非上市公司金融机构	2025-06-30
利好	分红转增	10派9.0元(含税)	2025-04-26
一般消息	募资投向	公司购买资产	2025-04-26
一般消息	高管变动	因工作安排	2025-04-24
一般消息	重大事项	公司股东股份解押	2025-03-07
一般消息	募资投向	公司购买资产	2025-03-05
一般消息	重大事项	公司股东股份解押	2025-02-27
利好	重大事项	参股拟上市公司或非上市公司金融机构	2024-12-31
一般消息	重大事项	公司股东股份解押	2024-12-26
一般消息	重大事项	关联交易	2024-11-30

一年消息统计

	所有消息	重大消息	非重大消息
利好	3条	0条	3条
利空	0条	0条	0条

行业面诊股

诊断结果：7.7行业面打败了84%的股票中药行业最新资金流向

近10日来该行业走势不明显，明显跑赢大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。

行业面得分最高的股票

行业走势

近10日来该行业走势不明显，明显跑赢大盘。

[{"date":"2025.11.10","price":"0.53","value":"0.84"},{"date":"2025.11.07","price":"-0.25","value":"0.89"},{"date":"2025.11.06","price":"0.97","value":"-0.37"},{"date":"2025.11.05","price":"0.23","value":"0.46"},{"date":"2025.11.04","price":"-0.41","value":"-0.65"},{"date":"2025.11.03","price":"0.55","value":"0.77"},{"date":"2025.10.31","price":"-0.81","value":"2.11"},{"date":"2025.10.30","price":"-0.73","value":"-1.13"},{"date":"2025.10.29","price":"0.70","value":"-0.32"},{"date":"2025.10.28","price":"-0.22","value":"-0.54"},{"date":"2025.10.27","price":"1.18","value":"-0.12"},{"date":"2025.10.24","price":"0.71","value":"-0.63"},{"date":"2025.10.23","price":"0.22","value":"-0.36"},{"date":"2025.10.22","price":"-0.07","value":"0.70"},{"date":"2025.10.21","price":"1.36","value":"0.86"},{"date":"2025.10.20","price":"0.63","value":"0.20"},{"date":"2025.10.17","price":"-1.95","value":"-0.94"},{"date":"2025.10.16","price":"0.10","value":"0.75"},{"date":"2025.10.15","price":"1.22","value":"1.37"},{"date":"2025.10.14","price":"-0.62","value":"0.32"},{"date":"2025.10.13","price":"-0.19","value":"-0.86"}]

上证指数,中药行业

行业排名

排名	股票名称	1月涨跌幅	5日涨跌幅	评分
1	康缘药业	2483.61%	5.99%	6.8分
2	特一药业	32.27%	2.75%	6.3分
3	以岭药业	22.06%	7.20%	7.0分
4	众生药业	21.94%	1.04%	6.2分
5	维康药业	18.07%	-4.41%	5.5分
6	华神科技	14.55%	7.18%	6.4分
7	达仁堂	13.49%	7.90%	7.0分
8	贵州百灵	12.62%	2.22%	5.7分
9	粤万年青	12.09%	3.61%	5.7分
10	ST葫芦娃	11.42%	3.17%	5.3分
11	精华制药	11.16%	4.05%	6.5分
12	盘龙药业	9.63%	2.94%	6.2分
13	济川药业	9.02%	7.94%	7.0分
14	康恩贝	8.64%	0.84%	6.7分
15	金花股份	7.98%	0.90%	6.6分
16	益盛药业	7.31%	1.58%	6.1分
17	康惠股份	7.25%	2.76%	5.7分
18	马应龙	7.07%	2.31%	6.3分
19	益佰制药	7.02%	3.03%	6.6分
20	上海凯宝	6.80%	3.21%	6.4分
21	白云山	6.73%	2.29%	7.0分
22	佛慈制药	6.34%	1.43%	6.0分
23	华润三九	6.29%	4.38%	7.0分
24	吉林敖东	5.66%	0.33%	5.9分
25	信邦制药	5.63%	1.81%	6.7分
26	陇神戎发	5.40%	1.77%	5.9分
27	新光药业	5.35%	0.31%	5.5分
28	广誉远	5.27%	4.33%	7.0分
29	新天药业	4.82%	0.63%	5.7分
30	嘉应制药	4.64%	3.68%	6.0分
31	汉森制药	4.54%	3.25%	6.2分
32	亚宝药业	4.53%	1.91%	6.7分
33	东阿阿胶	4.47%	2.77%	6.2分
34	中恒集团	4.40%	1.42%	6.0分
35	桂林三金	4.27%	1.52%	7.0分
36	千金药业	4.04%	0.93%	6.8分
37	天目药业	3.52%	-1.83%	5.8分
38	仁和药业	3.44%	0.32%	6.1分
39	启迪药业	3.40%	-4.62%	4.3分
40	-	3.18%	-2.63%	分
41	九芝堂	2.87%	-1.38%	6.0分
42	红日药业	2.70%	-1.30%	5.9分
43	-	2.28%	0.15%	分
44	康美药业	1.97%	-0.48%	6.2分
45	寿仙谷	1.57%	2.12%	5.8分
46	华森制药	1.54%	0.73%	5.7分
47	羚锐制药	1.11%	1.55%	6.1分
48	振东制药	1.03%	-3.10%	5.0分
49	云南白药	0.93%	1.63%	7.0分
50	方盛制药	0.93%	-0.74%	5.5分
51	同仁堂	0.73%	1.99%	6.0分
52	江中药业	0.19%	0.09%	5.8分
53	健民集团	-0.10%	0.84%	5.9分
54	沃华医药	-0.47%	1.44%	6.6分
55	贵州三力	-0.65%	1.57%	5.8分
56	恩威医药	-1.45%	-2.21%	5.3分
57	步长制药	-1.57%	2.21%	6.2分
58	天士力	-1.78%	0.59%	6.0分
59	昆药集团	-2.00%	0.88%	5.2分
60	珍宝岛	-2.11%	-0.68%	5.5分
61	奇正藏药	-2.45%	0.43%	5.6分
62	葵花药业	-2.82%	2.00%	4.7分
63	佐力药业	-4.28%	1.55%	4.9分
64	片仔癀	-6.82%	1.16%	6.1分
65	太极集团	-7.29%	-2.48%	5.2分
66	ST香雪	-9.55%	-0.20%	3.9分
67	*ST长药	-27.75%	-19.30%	3.6分
68	太龙药业	-	3.80%	6.7分
69	万邦德	-	-7.84%	5.3分

<上一页 1 2 3 4 5...12 下一页>

行业评级

最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。

综合评级

研究机构	评级日期	最新评级	上次评级
中信证券	2012-09-10	增持	增持
招商证券	2012-09-08	增持	增持
航天证券	2012-09-06	增持	-
中银国际	2012-09-05	增持	-
齐鲁证券	2012-09-05	增持	-

基本面诊股

诊断结果：8.1基本面打败了99%的股票连续3年业绩增长30%的公司

该公司运营状况良好，多数机构认为该股长期投资价值较高。

个股深一度

潜在高分红能力：中（92.5分）

基本面得分最高的股票

[ 截止日期：2025-09-30 ]公司经营

盈利能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 3/109 ， 2/109。

[{"date":"2025-09-30","value":"20.60","vol":"4.74"},{"date":"2025-06-30","value":"15.46","vol":"3.98"},{"date":"2025-03-31","value":"6.79","vol":"2.21"},{"date":"2024-12-31","value":"24.65","vol":"4.80"},{"date":"2024-09-30","value":"20.19","vol":"2.91"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
净资产收益率(%)	20.60	15.46	6.79	24.65	20.19
行业(%)	4.74	3.98	2.21	4.80	2.91

该指标值越高，盈利能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"81.02","vol":"52.31"},{"date":"2025-06-30","value":"81.33","vol":"52.86"},{"date":"2025-03-31","value":"76.77","vol":"53.38"},{"date":"2024-12-31","value":"75.82","vol":"52.74"},{"date":"2024-09-30","value":"75.00","vol":"53.11"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
销售毛利率(%)	81.02	81.33	76.77	75.82	75.00
行业(%)	52.31	52.86	53.38	52.74	53.11

该指标值越高，盈利能力越强，行业排名越靠前。

成长能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 9/109 ， 20/109。

[{"date":"2025-09-30","value":"10.23","vol":"-7.31"},{"date":"2025-06-30","value":"10.14","vol":"-7.31"},{"date":"2025-03-31","value":"12.29","vol":"-7.18"},{"date":"2024-12-31","value":"5.72","vol":"-7.35"},{"date":"2024-09-30","value":"10.07","vol":"-5.11"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
营业收入同比增长率(%)	10.23	10.14	12.29	5.72	10.07
行业(%)	-7.31	-7.31	-7.18	-7.35	-5.11

该指标值越高，成长能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"13.43","vol":"-2.54"},{"date":"2025-06-30","value":"14.85","vol":"2.98"},{"date":"2025-03-31","value":"13.89","vol":"-37.19"},{"date":"2024-12-31","value":"27.19","vol":"-146.29"},{"date":"2024-09-30","value":"23.10","vol":"61.78"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
净利润同比增长率(%)	13.43	14.85	13.89	27.19	23.10
行业(%)	-2.54	2.98	-37.19	-146.29	61.78

该指标值越高，成长能力越强，行业排名越靠前。

营运能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 7/109 ， 37/109。

[{"date":"2025-09-30","value":"0.56","vol":"0.35"},{"date":"2025-06-30","value":"0.40","vol":"0.24"},{"date":"2025-03-31","value":"0.20","vol":"0.12"},{"date":"2024-12-31","value":"0.72","vol":"0.50"},{"date":"2024-09-30","value":"0.57","vol":"0.37"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
总资产周转率(次)	0.56	0.40	0.20	0.72	0.57
行业(次)	0.35	0.24	0.12	0.50	0.37

该指标值越高，营运能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"1.37","vol":"1.73"},{"date":"2025-06-30","value":"0.93","vol":"1.18"},{"date":"2025-03-31","value":"0.58","vol":"0.61"},{"date":"2024-12-31","value":"1.88","vol":"2.42"},{"date":"2024-09-30","value":"1.55","vol":"1.81"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
存货增长率(次)	1.37	0.93	0.58	1.88	1.55
行业(次)	1.73	1.18	0.61	2.42	1.81

该指标值越高，营运能力越强，行业排名越靠前。

现金流能力：数据暂时不全，请后续关注

[{"date":"2025-09-30","value":"14.31","vol":"9.48"},{"date":"2025-06-30","value":"22.07","vol":"20.05"},{"date":"2025-03-31","value":"11.52","vol":"-0.23"},{"date":"2024-12-31","value":"70.89","vol":"15.64"},{"date":"2024-09-30","value":"6.97","vol":"5.86"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
现金流量净额/营业收入	14.31	22.07	11.52	70.89	6.97
行业	9.48	20.05	-0.23	15.64	5.86

该指标值越高，现金流能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"","vol":"0.00"},{"date":"2025-06-30","value":"0.68","vol":"1.02"},{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"1.51","vol":"1.45"},{"date":"2024-09-30","value":"","vol":"0.00"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
资本支出／折旧和摊销	-	0.68	-	1.51	-
行业	0.00	1.02	0.00	1.45	0.00

该指标值越低，现金流能力越强，行业排名越靠前。

短期偿债能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 32/109 ， 18/109。

[{"date":"2025-09-30","value":"1.08","vol":"3.05"},{"date":"2025-06-30","value":"0.98","vol":"2.90"},{"date":"2025-03-31","value":"1.01","vol":"2.99"},{"date":"2024-12-31","value":"1.31","vol":"2.88"},{"date":"2024-09-30","value":"1.18","vol":"3.25"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
流动比率	1.08	0.98	1.01	1.31	1.18
行业	3.05	2.90	2.99	2.88	3.25

该指标值越接近2，短期偿债能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"0.66","vol":"2.21"},{"date":"2025-06-30","value":"0.58","vol":"2.13"},{"date":"2025-03-31","value":"0.65","vol":"2.22"},{"date":"2024-12-31","value":"0.92","vol":"2.11"},{"date":"2024-09-30","value":"0.84","vol":"2.43"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
速动比率	0.66	0.58	0.65	0.92	0.84
行业	2.21	2.13	2.22	2.11	2.43

该指标值越接近1，短期偿债能力越强，行业排名越靠前。

长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 8/109 ， 17/109。

[{"date":"2025-09-30","value":"42.96","vol":"33.12"},{"date":"2025-06-30","value":"44.36","vol":"33.87"},{"date":"2025-03-31","value":"38.20","vol":"33.29"},{"date":"2024-12-31","value":"38.60","vol":"34.05"},{"date":"2024-09-30","value":"40.61","vol":"32.87"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
资产负债率(%)	42.96	44.36	38.20	38.60	40.61
行业(%)	33.12	33.87	33.29	34.05	32.87

该指标值越接近50%，长期偿债能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"0.76","vol":"0.75"},{"date":"2025-06-30","value":"0.81","vol":"0.74"},{"date":"2025-03-31","value":"0.62","vol":"0.72"},{"date":"2024-12-31","value":"0.63","vol":"0.75"},{"date":"2024-09-30","value":"0.69","vol":"3.20"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
产权比率 (%)	0.76	0.81	0.62	0.63	0.69
行业(%)	0.75	0.74	0.72	0.75	3.20

该指标值越高，长期偿债能力越强，行业排名越靠前。

机构评级

最近60个交易日，机构评级以买入为主，认为该股票非常值得关注。

研究机构	评级日期	最新评级	上次评级
兴业证券	2025-11-04	增持
长城证券	2025-11-03	增持	增持
浙商证券	2025-10-30	买入	买入
中信建投证券	2025-09-05	买入
东海证券	2025-08-22	买入
开源证券	2025-08-20	买入

机构预测

机构预测该股2025年每股收益与前一年相同，长期投资价值一般。

[{"date":"2021","yellowRectValue":"3.62","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"4.65","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"5.68","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"7.23","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"8.33","blueLineValue":"1.47","type":"YC"}]

[羚锐制药]

技术面诊股
资金面诊股
消息面诊股
行业面诊股
基本面诊股

【数据基于历史，不代表未来趋势；诊股基于模型与测试，需要投资者根据不同行情合理运用、独立判断、控制风险】

证券咨询服务提供：浙江同花顺云软件有限公司 [编号：zx0050]